https://doi.org/10.1016/j.immuni.2024.03.021
M
Miao Hu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
160
Papers
2.4K
Citations
27
h-index
71
i10-index
Miao Hu is an academic researcher. The author has contributed to research in topics: Lipoproteins and Cardiovascular Health & Pharmacogenetics and Drug Metabolism & Diabetes, Cardiovascular Risks, and Lipoproteins. The author has an h-index of 27, co-authored 136 publications.
ORCID: 0000-0001-5403-4095Papers by this author
works25-Hydroxycholesterol regulates lysosome AMP kinase activation and metabolic reprogramming to educate immunosuppressive macrophages
2024 · Immunity · 125 citations
Endothelial Cell‐Derived Lactate Triggers Bone Mesenchymal Stem Cell Histone Lactylation to Attenuate Osteoporosis
2023 · Advanced Science · 104 citations
https://doi.org/10.1002/advs.202301300
FOS/GOS attenuates high-fat diet induced bone loss via reversing microbiota dysbiosis, high intestinal permeability and systemic inflammation in mice
2021 · Metabolism · 95 citations
https://doi.org/10.1016/j.metabol.2021.154767
Development of genome-wide polygenic risk scores for lipid traits and clinical applications for dyslipidemia, subclinical atherosclerosis, and diabetes cardiovascular complications among East Asians
2021 · Genome Medicine · 35 citations
https://doi.org/10.1186/s13073-021-00831-z
Naringenin is a Potential Anabolic Treatment for Bone Loss by Modulating Osteogenesis, Osteoclastogenesis, and Macrophage Polarization
2022 · Frontiers in Pharmacology · 29 citations
https://doi.org/10.3389/fphar.2022.872188
Genistein induces endocrine resistance in human breast cancer by suppressing H3K27 trimethylation
2022 · Endocrine Related Cancer · 14 citations
https://doi.org/10.1530/erc-22-0191
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat